7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
https://doi.org/10.1081/bip-120037181
Copy DOIPublication Date: Dec 24, 2004 | |
Citations: 11 |
A fundamental assumption in the design and analysis of an active-control noninferiority trial is that the active control is truly effective. If this assumption does not hold, i.e., the active control is not effective, a harmful drug may be approved based on the result of a noninferiority trial. The assessment of the assumption is usually based on statistically significant results of historical randomized clinical trials on the active control, in which the conclusion may be falsely positive. This false positive rate, however, is not taken into consideration in current noninferiority trial test procedures. In this paper, various possible hypotheses for noninferiority trials are presented. The noninferiority hypotheses correctly associated with the objective of noninferiority trials are suggested. However, since there are no data collected for placebo in a noninferiority trial, this hypothesis cannot be directly tested by using data from noninferiority studies alone. The claim of noninferiority is based on the significant test for the control effect in historical trials and the significant test for noninferiority in a current noninferiority trial with a given fraction retention or margin. The false positive rate associated with such noninferiority test procedure is defined in this paper. The simulation result demonstrates the magnitude of the false positive rate inflation associated with the noninferiority test procedure.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.